Well LKE is a high risk investment and the risk is for the upside and the downside. If Hazem and Novonix testing of the purity and efficacy of the LCE is 99.9% and above then the product is well qualified and will be in great demand. The other big hurdle is financing and if the BOD can come up with a good working model we will be rewarded. The problem is it will then be much more costly to invest/get set. So at present it is a punt on how it is managed by the BOD. GLTAH
Ann: Cleansing Prospectus Closed and App 3Y, page-17
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LKE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $65.07M | |||
| Open | High | Low | Value | Volume |
| 4.0¢ | 4.1¢ | 3.9¢ | $256.9K | 6.439M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 1434089 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 182279 | 4 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| LKE (ASX) Chart |